首页 | 本学科首页   官方微博 | 高级检索  
检索        

乌司他丁联合血必净治疗老年重症肺炎的临床研究
引用本文:陈勇坚,高永祺,彭玉维.乌司他丁联合血必净治疗老年重症肺炎的临床研究[J].岭南急诊医学杂志,2014(4):269-270.
作者姓名:陈勇坚  高永祺  彭玉维
作者单位:广东省江门市中心医院急诊科,529030
摘    要:目的:探讨乌司他丁联合血必净治疗老年重症肺炎的疗效。方法:将160例老年重症肺炎患者随机分为对照组(A组)、乌司他丁组(B组)、血必净组(C组)、乌司他丁+血必净联合组(D组)各40例,A组予常规治疗,B组、C组、D组在A组基础上分别给予静脉滴注乌司他丁、血必净、乌司他丁和血必净7 d。比较各组治疗前后血浆肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)、降钙素原(PCT)水平、动脉血气分析,抗生素使用时间、机械通气时间、ICU住院时间和28d生存率。结果:D组治疗后TNF-α、IL-6、PCT显著下降,PaO_2、PaO_2/FiO_2升高程度及P(A-a)O_2下降幅度明显大于其他三组;抗生素使用时间、机械通气时间、ICU住院时间明显少于其他三组,28 d生存率则明显高于其他三组,P均0.05。结论:乌司他丁联合血必净辅助治疗老年重症肺炎疗效显著。

关 键 词:老年  重症肺炎  乌司他丁  血必净

The Clinical Study of Ulinastatin and Xuebijing on Elderly Patients with Severe Pneumonia
CHEN Yong-jian,GAO Yong-qi,Peng Yu-wei.The Clinical Study of Ulinastatin and Xuebijing on Elderly Patients with Severe Pneumonia[J].Lingnan Journal of Emergency Medicine,2014(4):269-270.
Authors:CHEN Yong-jian  GAO Yong-qi  Peng Yu-wei
Institution:(Department of Emergency, Center Hospital of Jiangmen , Jiangmen , Guangdong Province, 529030 )
Abstract:Objective: To explore the therapeutic effects of Ulinastatin and Xuebijing on elderly patients with severe pneumonia. Methods: 160 elderly patients with severe pneumonia were randomly divided into control group (group A), Ulinastatin group (group B), Xuebijing group (group C) and combined group (group D). The group A was given routine treatment. On the basis of group A, the group B was given Ulinastatin, the group C was given Xuebijing, the group D was given Ulinastatin and Xuebijing for 7 days. Before treatment and on 8th day from the beginning, blood concentrations of TNF-α, IL-6, PCT were detected, while PaO2, PaO2/FiO2, P(A-a)O2 of blood gas analysis were monitored, and the times of antibiotic used , mechanical ventilation, in ICU and the 28-day survival rate were compared among the four groups. Results: TNF-α,IL-6,PCT,P(A-a)O2 in all groups decreased after treatment, and the descending degree in group D was significantly obvious than those in the other groups. PaO2, PaO2/FiO2 in all the groups increased after treatment, and the increasing degree in group D was more obvious than those in the other groups o The times of antibiotic used, mechanical ventilation and the days in ICU on group D were significantly shorter than those in the other groups , but the 28-day survival rate was significantly higher than that in the other groups, all P〈0.05. Conclnsions:The treatment of Ulinastatin combined with Xuebijing has significant therapeutic effects on elderly patients with severe pneumonia.
Keywords:elderly  severe pneumonia  Ulinastatin  Xuebijing
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号